Shannon Marshall

1.9k total citations
40 papers, 1.2k citations indexed

About

Shannon Marshall is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Shannon Marshall has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Shannon Marshall's work include Monoclonal and Polyclonal Antibodies Research (12 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (7 papers). Shannon Marshall is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (7 papers). Shannon Marshall collaborates with scholars based in United States, France and United Kingdom. Shannon Marshall's co-authors include Stephen L. Mayo, Arthur J. Chirino, Marylouise Ary, Greg A. Lazar, John R. Desjarlais, Christina L. Vizcarra, Hyun‐Jin Tae, Mark I. Talan, Lieping Chen and Solomon Langermann and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shannon Marshall

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon Marshall United States	21	726	320	283	250	146	40	1.2k
Django Sussman United States	18	1.0k 1.4×	574 1.8×	175 0.6×	476 1.9×	80 0.5×	33	1.6k
Enrico L. DiGiammarino United States	18	972 1.3×	887 2.8×	206 0.7×	168 0.7×	39 0.3×	30	1.5k
Liya Roudaia United States	8	662 0.9×	368 1.1×	305 1.1×	57 0.2×	44 0.3×	9	1.2k
Torbjörn Gräslund Sweden	24	1.1k 1.5×	450 1.4×	189 0.7×	1.1k 4.2×	45 0.3×	67	1.7k
Alistair J. Henry United Kingdom	26	903 1.2×	393 1.2×	778 2.7×	741 3.0×	44 0.3×	51	2.0k
Shrikant Deshpande United States	18	457 0.6×	600 1.9×	358 1.3×	606 2.4×	41 0.3×	57	1.4k
Corey P. Causey United States	22	1.1k 1.5×	466 1.5×	689 2.4×	185 0.7×	81 0.6×	37	2.0k
Violette Paragas United States	14	726 1.0×	498 1.6×	532 1.9×	453 1.8×	27 0.2×	28	1.5k
Penelope M. Drake United States	24	896 1.2×	649 2.0×	511 1.8×	597 2.4×	31 0.2×	33	1.9k
De-Kuan Chang Taiwan	15	465 0.6×	241 0.8×	185 0.7×	156 0.6×	24 0.2×	17	895

Countries citing papers authored by Shannon Marshall

Since Specialization

Citations

This map shows the geographic impact of Shannon Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Marshall more than expected).

Fields of papers citing papers by Shannon Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Marshall. The network helps show where Shannon Marshall may publish in the future.

Co-authorship network of co-authors of Shannon Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Marshall. A scholar is included among the top collaborators of Shannon Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Marshall. Shannon Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lopez, Juanita, Mohammed Milhem, Marcus O. Butler, et al.. (2025). Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies. Cell Reports Medicine. 6(4). 101994–101994. 2 indexed citations

Friedman, Claire F., Juanita Lopez, Mark R. Middleton, et al.. (2024). 750P Phase I safety and efficacy of brenetafusp, a PRAME × CD3 ImmTAC T cell engager, in platinum resistant ovarian cancer (PROC). Annals of Oncology. 35. S569–S570. 1 indexed citations

Wan, Min, Qiuye Zhao, Shannon Marshall, et al.. (2024). Phosphoribosyl modification of poly-ubiquitin chains at the Legionella-containing vacuole prohibiting autophagy adaptor recognition. Nature Communications. 15(1). 7481–7481. 4 indexed citations

Hamid, Omid, Juanita Lopez, Daniel G. Olson, et al.. (2024). Phase 1 safety and efficacy of IMC-F106C, a PRAME × CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM).. Journal of Clinical Oncology. 42(16_suppl). 9507–9507. 10 indexed citations

Dibitetto, Diego, Shannon Marshall, Andrea Sanchi, et al.. (2022). DNA-PKcs promotes fork reversal and chemoresistance. Molecular Cell. 82(20). 3932–3942.e6. 28 indexed citations

Ribas, Antoni, Alain P. Algazi, Paolo A. Ascierto, et al.. (2021). Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature Communications. 12(1). 5022–5022. 1 indexed citations

Pegram, Mark D., Erika Hamilton, Antoinette R. Tan, et al.. (2021). First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer. Molecular Cancer Therapeutics. 20(8). 1442–1453. 73 indexed citations

Ribas, Antoni, Alain P. Algazi, Paolo A. Ascierto, et al.. (2020). PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature Communications. 11(1). 60 indexed citations

Faça, Vítor M., Ethan J. Sanford, Shagun Gupta, et al.. (2020). Maximized quantitative phosphoproteomics allows high confidence dissection of the DNA damage signaling network. Scientific Reports. 10(1). 18056–18056. 12 indexed citations

10.

McMurtry, C. Meghan, et al.. (2019). Massage therapy for symptom reduction and improved quality of life in children with cancer in palliative care: A pilot study. Complementary Therapies in Medicine. 48. 102263–102263. 16 indexed citations

11.

Nakano, K, Shannon Marshall, Yasunori Sato, et al.. (2016). A comparison of cetuximab-containing regimens for recurrent/metastatic squamous cell head and neck carcinoma: the clinical significance of weekly paclitaxel and cetuximab. Annals of Oncology. 27. vi346–vi346. 1 indexed citations

12.

Podojil, Joseph R., Linda N. Liu, Shannon Marshall, et al.. (2013). B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. Journal of Autoimmunity. 44. 71–81. 46 indexed citations

13.

Gundry, Rebekah L., Daniel R. Riordon, Yelena S. Tarasova, et al.. (2012). A Cell Surfaceome Map for Immunophenotyping and Sorting Pluripotent Stem Cells. Molecular & Cellular Proteomics. 11(8). 303–316. 52 indexed citations

14.

Vizcarra, Christina L., Naigong Zhang, Shannon Marshall, et al.. (2007). An improved pairwise decomposable finite‐difference Poisson–Boltzmann method for computational protein design. Journal of Computational Chemistry. 29(7). 1153–1162. 23 indexed citations

15.

Marshall, Shannon, et al.. (2006). Simple electrostatic model improves designed protein sequences. Protein Science. 15(8). 2014–2018. 15 indexed citations

16.

Wojciechowski, Wojciech, Huifen Li, Shannon Marshall, Chiara Dell’Agnola, & Igor Espinoza‐Delgado. (2005). Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms. The Journal of Immunology. 174(12). 7859–7868. 33 indexed citations

17.

Marshall, Shannon, Christina L. Vizcarra, & Stephen L. Mayo. (2005). One‐ and two‐body decomposable Poisson‐Boltzmann methods for protein design calculations. Protein Science. 14(5). 1293–1304. 43 indexed citations

18.

Marshall, Shannon, Greg A. Lazar, Arthur J. Chirino, & John R. Desjarlais. (2003). Rational design and engineering of therapeutic proteins. Drug Discovery Today. 8(5). 212–221. 134 indexed citations

19.

Lazar, Greg A., et al.. (2003). Designing proteins for therapeutic applications. Current Opinion in Structural Biology. 13(4). 513–518. 34 indexed citations

20.

Marshall, Shannon & Stephen L. Mayo. (2001). Achieving stability and conformational specificity in designed proteins via binary patterning11Edited by C. R. Matthews. Journal of Molecular Biology. 305(3). 619–631. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact